These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6300912)

  • 1. Dihydropyridine receptor in rat brain labeled with [3H]nimodipine.
    Bellemann P; Schade A; Towart R
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2356-60. PubMed ID: 6300912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes.
    Bellemann P
    FEBS Lett; 1984 Feb; 167(1):88-92. PubMed ID: 6199232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
    Glossmann H; Ferry DR
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain.
    Peroutka SJ; Allen GS
    J Neurosurg; 1983 Dec; 59(6):933-7. PubMed ID: 6631515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism.
    Young HS; Skita V; Mason RP; Herbette LG
    Biophys J; 1992 May; 61(5):1244-55. PubMed ID: 1318093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives.
    Takahashi D; Oyunzul L; Onoue S; Ito Y; Uchida S; Simsek R; Gunduz MG; Safak C; Yamada S
    Biol Pharm Bull; 2008 Mar; 31(3):473-9. PubMed ID: 18310913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
    Goll A; Glossmann H; Mannhold R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):303-12. PubMed ID: 3027587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.
    Striessnig J; Zernig G; Glossmann H
    Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative calcium channels in skeletal muscle microsomes.
    Ferry DR; Glossmann H
    FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding.
    Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F
    J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.
    Thayer SA; Welcome M; Chhabra A; Fairhurst AS
    Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart.
    Ferry DR; Glossmann H; Kaumann AJ
    Br J Pharmacol; 1985 Apr; 84(4):811-24. PubMed ID: 2408698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of 1,4-dihydropyridine and beta-adrenergic receptor sites in coronary artery smooth muscle membranes.
    Drimal J
    Cell Signal; 1991; 3(3):225-32. PubMed ID: 1716451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of [3H]nimodipine binding to sarcolemmal membranes from rat vas deferens and its regulation by guanine nucleotide.
    Higo K; Saito H; Matsuki N
    Jpn J Pharmacol; 1988 Oct; 48(2):213-21. PubMed ID: 2850380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.